Drugs / ATH03
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01284582 | May 2011 → Jul 2012 | — | Affiris AG | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ATH03 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01284582 ↗ |
| Modality | Vaccine | “a New Vaccine Against the Cholesterol Ester Transfer Protein (CETP)” NCT01284582 ↗ |